Lars Jörgen Stubberud

Lars Jörgen Stubberud has extensive work experience in the pharmaceutical industry.

Lars Jörgen is currently working at Calliditas Therapeutics as the Head of Technical Operations, a role they have held since March 2023. Prior to this position, Lars was the Head of Pharmaceutical Development and Manufacturing at Calliditas Therapeutics from August 2020 to February 2023.

Before joining Calliditas Therapeutics, Lars worked at Alexion Pharmaceuticals, Inc. as the Senior Director and Head of Quality Europe and College Park Distribution from November 2019 to July 2020. Lars Jörgen also held the position of Director Regional Quality Assurance at Alexion Pharma GmbH from May 2017 to October 2019.

Lars has also gained experience at other pharmaceutical companies. Lars Jörgen worked as the Director of Regulatory CMC and Quality Assurance at Biogen from September 2015 to May 2017. Prior to that, they held the position of Director of Regulatory Affairs CMC at Cubist Pharmaceuticals from July 2014 to September 2015.

Earlier in their career, Lars worked at AstraZeneca R&D as the Director of QA Manufacturing and Pharmaceutical Development from January 2011 to June 2014. Lars Jörgen also held various positions at AstraZeneca, including Associate Director of Pharmaceutical Development Quality Assurance from May 2008 to December 2010. Lars began their career at Astra Läkemedel AB as a Research Scientist from January 1992 to January 1994.

Overall, Lars Jörgen Stubberud has over 30 years of experience in the pharmaceutical industry, with expertise in quality assurance, regulatory affairs, and pharmaceutical development.

Lars Jörgen Stubberud completed their education in the field of pharmaceutical sciences. Lars Jörgen first pursued a Master of Pharmaceutical Sciences degree at the University of Oslo (UiO) from 1983 to 1988. Later, they went on to obtain a Doctor of Pharmacy (Pharm.D.) degree in Pharmaceutical Technology from the University of Oslo from 1992 to 1997.